Company Overview and News

25
12 Of The Greatest Moat-Worthy REITs

2018-09-14 seekingalpha - 1
REITs are unique in terms of their ability to grow moats; there are essentially two valuable levers that the company can (and should) utilize to build competitive advantage.
JCP DCT OPRF PSA.A CVS SHLD AMT EQY PSB ROST PSA EQIT WPC DRE KDNUU SBRA PSAXZ CCP VTR PPS COST O KND PLD

7
Should You Add CBRE Group (CBRE) Stock to Your Portfolio Now?

2018-09-10 zacks
CBRE Group (CBRE - Free Report) has a robust scale as the largest commercial real estate services and investment firm (based on 2017 revenues). It is among the few companies offering a full suite of services to multi-national clients. Moreover, the company has grown organically, and banked on strategic acquisitions to boost its service offerings and geographic reach. Most recently, the company announced the acquisition of a consulting firm focused on serving healthcare facility owners named Noveen Consulting.
DWHHF CIG DTCWY CIGI PSB BRK.A CBG KO CBRE

 
PSB / PS Business Parks, Inc. 8-K (Current Report)

2018-09-10 sec.gov
8K Filing (090718) UNITED STATES SECURITIES AND EXCHANGE COMMI
PSB

3
Outfront Media (OUT) Runs OOH Campaign With Dream Town Realty

2018-09-07 zacks
Outfront Media Inc. (OUT - Free Report) recently collaborated with Chicago’s Dream Town Realty for an out-of-home (OOH) campaign, celebrating the 20th anniversary of the latter. The “Be You” campaign is aimed at encouraging audiences to express themselves by sharing photos and raises brand awareness for the real estate brokerage firm.
VICI PSB ALLY OUT

3
Duke Realty (DRE) Prices Senior Unsecured Notes Worth $450M

2018-09-05 zacks
Duke Realty Corporation (DRE - Free Report) has announced the pricing of its 4% senior unsecured notes through the company’s operating partnership. The $450-million notes are priced at 98.26% of the principal amount and carry a yield of 4.132%.
DRE VICI PSB

3
UMH Properties (UMH) Eyes Expansion, Buys Indiana Community

2018-09-03 zacks
Residential real estate investment trust (REIT) UMH Properties, Inc. (UMH - Free Report) recently closed the acquisition of an Indiana community for a total price of $3,500,000. The buyout is a strategic fit for the company as it enables UMH Properties to strengthen its position in the Indiana market.
VICI PSB BLD UMH

5
Here's Why You Should Hold Ventas in Your Portfolio Now

2018-08-30 zacks
Ventas Inc. (VTR - Free Report) has an impressive and well-diversified portfolio of senior housing and healthcare properties that positions the company well for long-term growth. However, a large portion of the company’s revenues originates from a few tenants, which exposes it to concentration risks.
VTR BKD NVMI PSB VTRB SMG

8
Equinix & VMware Partner to Offer Hybrid Cloud Facility

2018-08-30 zacks
Equinix, Inc. (EQIX - Free Report) recently announced a partnership with VMware to offer private and secure connection to VMware Cloud, using Amazon Web Services (AWS), throughout Equinix’s International Business Exchange (IBX) data centers, globally.
EQIX NVMI VICI PSB SMG

 
Industrial REITs: The Need For Speed

2018-08-30 seekingalpha
Industrial REITs continue to be the standouts of the REIT sector. The “need for speed” among consumers and businesses has resulted in intense competition for well-located logistics distribution centers.
DRE PLDGP WSTC STAG EGP PSB PLD LPT

10
Liberty Properties Fortifies Southern California Portfolio

2018-08-29 zacks
Liberty Property Trust (LPT - Free Report) has been witnessing favorable demand for is properties in Southern California. The company recently acquired an industrial property at 1543 N. Alder Street in Rialto, in a bid to strengthen its foothold in the region and fully leased it within a week of the transaction.
VICI PSB PSEC URBN LPT PBB

10
Cedar Realty Acquires Leasehold Stake in Senator Square

2018-08-29 zacks
Recently, Cedar Realty Trust, Inc. (CDR - Free Report) announced that it has acquired a 99-year leasehold interest, including an option to purchase, at the Senator Square Shopping Center. This transaction reflects the company’s efforts to significantly expand and redevelop its properties in the vibrant neighborhood of Ward 7, as well as Washington, D.C.
CDR VICI PSB PSEC URBN PBB

1
Federal Realty's (FRT) 700 Santana Row Now 100% Pre-Leased

2018-08-28 zacks
Recently, Federal Realty Investment Trust (FRT - Free Report) inked a long-term lease with Splunk Inc., for 301,000 square feet of office space, at the company’s Class-A mixed used development project — 700 Santana Row. With this lease, the development is now 100% pre-leased.
ECR SPLK LMHA PSB LMHB NRE FRT LM AVB

3
Should You Buy PS Business Parks (PSB) Stock Right Now?

2018-08-28 zacks
Performance of REIT stocks so far this year has been affected by rate hike issues, rising supply in certain asset categories as well as a cautious approach of investors. But as this special hybrid asset class benefits from the favorable dynamics of the individual asset categories, investing in it often leads to big gains for investors. In fact, one such REIT stock, which has been displaying strength, is PS Business Parks Inc.
ECR LMHA PSB LMHB LSI CDORO CDOR LM

 
Will CoreCivic's Buyout of Baltimore SSA Property Bear Fruit?

2018-08-27 zacks
In a bid to expand its portfolio of government-leased real estate assets, CoreCivic, Inc. (CXW - Free Report) recently acquired a Social Security Administration (SSA) office building in Baltimore, MD, spanning 540,566 square feet of area. The company has shelled out $242 million for this purchase.
CXW NRE PSB

 
Why Is PS Business Parks (PSB) Up 3.7% Since Last Earnings Report?

2018-08-23 zacks
It has been about a month since the last earnings report for PS Business Parks (PSB - Free Report) . Shares have added about 3.7% in that time frame, outperforming the S&P 500.
PSB

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to PSB / PS Business Parks, Inc. on message board site Silicon Investor.

PSB Bancorp (PSBI) PSB Bancorp (PSBI) PSB Bancorp (PSBI)